This inventor holds 5 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Membrana Gmbh, 3M Innovative Properties Company, Acordis Industrial Fibers Gmbh. Active years: 1992-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 21 
1 out of 22,398 
1 out of 4 
Years Active: 1992-2018
Title: Horst-Dieter Lemke: Innovating Leukocyte Elimination Methods
Introduction
Horst-Dieter Lemke is a distinguished inventor based in Obernburg, Germany, with an impressive portfolio of five patents. His contributions to the field of medical technology, particularly in blood treatment methods, have positioned him as a noteworthy figure in the realm of healthcare innovations.
Latest Patents
Among his latest innovations is a method for the elimination of leukocytes from blood. This inventive process involves treating blood within an arrangement of organic polymer-based fibers. The blood is channeled along these fibers, where leukocytes are effectively reduced via adsorption. The system is meticulously designed, featuring an inlet and outlet arrangement to guide the blood through the housing containing the fibers. Notably, the arrangement is characterized by its high degree of order, facilitating efficient blood flow over the fiber surfaces. Additionally, this innovative method generates the complement activation product C5a in concentrations of at least 10 μg per square meter of fiber surface, demonstrating its potential in advancing blood treatment techniques.
Career Highlights
Throughout his career, Horst-Dieter Lemke has worked with reputable companies, including Membrana GmbH and Akzo N.V. These roles have allowed him to develop and refine his innovative approaches to medical technologies, leveraging his expertise to contribute significantly to the field.
Collaborations
Lemke has collaborated with notable colleagues, including Bodo von Harten and Martin König. These partnerships have played a vital role in enhancing his research and innovation capabilities, leading to significant advancements in blood treatment technologies.
Conclusion
Horst-Dieter Lemke's work in developing methods for leukocyte elimination reflects a strong commitment to improving medical treatments. His innovative spirit and collaboration with key professionals in the industry continue to drive forward the advancement of healthcare solutions. As he builds on his existing patents, the potential for future breakthroughs in medical technology remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile